VYNE Therapeutics Inc. – Filings and Transcripts

NASDAQ: VYNE
Share price (5/28/26): $0.69
Market cap (5/28/26): $22.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Details of business combination or exchange offer – amended

Details of business combination or exchange offer

Draft registration statement

Business combination disclosure

Business combination disclosure

Ownership Filter

Nantahala Capital Management, LLC

Domzalski David

News Filter

Investor Presentation

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Material Definitive Agreement, Financial Statements or Exhibits

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement

Shareholder Vote Results

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC